| Ankylosing Spondylitis | Psoriatic Arthritis | Combined | |||
---|---|---|---|---|---|---|
 | Cases/Controls | Fully Adjusted ORb (95% CI) | Cases/Controls | Fully Adjusted ORb (95% CI) | Cases/Controls | Fully Adjusted ORb (95% CI) |
NSAID use only | 135/536 | 1.0 (ref) | 106/430 | 0.84 (0.61, 1.17) | 241/966 | 1.0 (ref) |
DMARD use only | 37/141 | 1.04 (0.65, 1.68) | 112/432 | 1.0 (ref) | 149/573 | 1.13 (0.87, 1.48) |
TNFi use only | < 11a/49 | 0.85 (0.39, 1.85) | > 65a/244 | 1.09 (0.74, 1.60) | 76/293 | 1.19 (0.85, 1.67) |
NSAID, DMARD | 27/86 | 1.29 (0.76, 2.20) | 62/248 | 0.97 (0.67, 1.40) | 89/334 | 1.17 (0.86, 1.58) |
NSAID, TNFi | 11/29 | 1.77 (0.79, 3.98) | 18/91 | 0.83 (0.47, 1.48) | 29/120 | 1.15 (0.72, 1.83) |
DMARD, TNFi | < 11a/34 | 0.91 (0.38, 2.16) | > 20a/96 | 0.77 (0.45, 1.34) | 31/130 | 0.93 (0.59, 1.47) |
NSAID, DMARD, TNFi | < 11a/19 | 1.99 (0.78, 5.12) | > 15a/55 | 1.23 (0.67, 2.25) | 26/74 | 1.55 (0.93, 2.57) |